These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2790213)

  • 41. Osmotic stimulation in DOC-salt hypertension: vasopressin and blood pressure.
    Crofton JT; Share L; Brooks DP
    J Hypertens; 1986 Jun; 4(3):307-12. PubMed ID: 3734447
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Endothelial function in deoxycorticosterone-NaCl hypertension: effect of calcium supplementation.
    Mäkynen H; Kähönen M; Wu X; Arvola P; Pörsti I
    Circulation; 1996 Mar; 93(5):1000-8. PubMed ID: 8598063
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Calcitonin gene-related peptide is a depressor of deoxycorticosterone-salt hypertension in the rat.
    Supowit SC; Zhao H; Hallman DM; DiPette DJ
    Hypertension; 1997 Apr; 29(4):945-50. PubMed ID: 9095081
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Increased endothelin-1 content in blood vessels of deoxycorticosterone acetate-salt hypertensive but not in spontaneously hypertensive rats.
    Larivière R; Thibault G; Schiffrin EL
    Hypertension; 1993 Mar; 21(3):294-300. PubMed ID: 8478038
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evaluation of medial hypertrophy in resistance vessels of spontaneously hypertensive rats.
    Owens GK; Schwartz SM; McCanna M
    Hypertension; 1988 Feb; 11(2):198-207. PubMed ID: 3343047
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ion transport in tonic and phasic vascular smooth muscle and changes during deoxycorticosterone hypertension.
    Jones AW; Miller LA
    Blood Vessels; 1978; 15(1-3):83-92. PubMed ID: 630138
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of a nonselective endothelin antagonist on vascular remodeling in deoxycorticosterone acetate-salt hypertensive rats. Evidence for a role of endothelin in vascular hypertrophy.
    Li JS; Larivière R; Schiffrin EL
    Hypertension; 1994 Aug; 24(2):183-8. PubMed ID: 8039842
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Role of blood pressure in regulating Na+/H+ exchange in vascular smooth muscle.
    Ellstrom DR; Honeyman TW; Scheid CR
    Am J Hypertens; 1994 Apr; 7(4 Pt 1):340-5. PubMed ID: 8031549
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Flow-induced vascular remodeling in the mesenteric artery of spontaneously hypertensive rats.
    Gao YJ; Yang LF; Stead S; Lee RM
    Can J Physiol Pharmacol; 2008 Nov; 86(11):737-44. PubMed ID: 19011668
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Vascular sodium pump activity kinetics in early and advanced stages of deoxycorticosterone-salt hypertension in rats.
    Songu-Mize E
    Life Sci; 1991; 49(26):2045-52. PubMed ID: 1660956
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hormone and electrolyte changes in post-deoxycorticosterone salt hypertension in rats.
    Morton JJ; Kenyon CJ; Beattie EC
    J Hypertens; 1990 Nov; 8(11):1021-6. PubMed ID: 1963184
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Deoxycorticosterone hypertension in the intact weanling rat without salt loading.
    Rodriguez-Sargent C; Torres-Negron I; Cangiano JL; Martinez-Maldonado M
    Hypertension; 1990 Feb; 15(2 Suppl):I112-6. PubMed ID: 2298466
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Tunica media remodeling in mesenteric arteries of hypertensive rats.
    McGuffee LJ; Little SA
    Anat Rec; 1996 Oct; 246(2):279-92. PubMed ID: 8888969
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of nitrendipine on cardiac and renal lesions and arterial hypertrophy. Protective effect of a low dose of calcium antagonist in deoxycorticosterone-induced hypertensive rats.
    Nickerson PA; Yang F
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1990; 59(4):215-21. PubMed ID: 1980171
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Altered vascular beta adrenoceptor-mediated relaxation in deoxycorticosterone-salt hypertensive rats.
    Fujimoto S; Dohi Y; Aoki K; Matsuda T
    J Pharmacol Exp Ther; 1988 Feb; 244(2):716-23. PubMed ID: 2831351
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Central mechanisms in DOC-salt hypertensive rats.
    Matsuguchi H; Sharabi FM; O'Connor G; Mark AL; Schmid PG
    Clin Exp Hypertens A; 1982; 4(8):1303-21. PubMed ID: 7116668
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mechanical properties of mesenteric resistance arteries from Dahl salt-resistant and salt-sensitive rats: role of endothelin-1.
    Intengan HD; Schiffrin EL
    J Hypertens; 1998 Dec; 16(12 Pt 2):1907-12. PubMed ID: 9886876
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of enalapril and amlodipine on small-artery structure and composition, and on endothelial dysfunction in spontaneously hypertensive rats.
    Sharifi AM; Li JS; Endemann D; Schiffrin EL
    J Hypertens; 1998 Apr; 16(4):457-66. PubMed ID: 9797191
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Extracellular calcium and altered vascular responsiveness in the deoxycorticosterone acetate-salt rat.
    Soltis EE; Field FP
    Hypertension; 1986 Jun; 8(6):526-32. PubMed ID: 3710558
    [TBL] [Abstract][Full Text] [Related]  

  • 60. High calcium diet effectively opposes the development of deoxycorticosterone-salt hypertension in rats.
    Mäkynen H; Arvola P; Vapaatalo H; Pörsti I
    Am J Hypertens; 1994 Jun; 7(6):520-8. PubMed ID: 7917150
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.